Genetics and Genetic Testing in Hereditary Colorectal Cancer

Gastroenterology

Volumn 149, Issue 5, 2015, Pages 1191-1203.e2

  Stoffel, Elena M ^a   Boland, C Richard ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cancer Genetics; Genetic Testing; Hereditary Cancer Syndromes

Indexed keywords

APC PROTEIN; DNA DIRECTED DNA POLYMERASE EPSILON; DNA GLYCOSYLASE MUTY; EPITHELIAL CELL ADHESION MOLECULE; FLUOROURACIL; MISMATCH REPAIR PROTEIN PMS2; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE LKB1; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; PROTEIN P53; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CANCER ADJUVANT THERAPY; COLONOSCOPY; COLORECTAL POLYP; COLORECTAL TUMOR; COWDEN SYNDROME; FAMILIAL CANCER; FAMILIAL COLON POLYPOSIS; FAMILY HISTORY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; GERMLINE MUTATION; HAMARTOMATOUS POLYPOSIS; HEREDITARY COLORECTAL CANCER; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; PERSONALIZED MEDICINE; PEUTZ JEGHERS SYNDROME; PRIORITY JOURNAL; WNT SIGNALING PATHWAY; FAMILY; FEMALE; GENETIC DISORDER; GENETIC PREDISPOSITION; GENETICS; MALE; PROCEDURES; RISK FACTOR;

COLORECTAL NEOPLASMS; FAMILY; FEMALE; GENETIC DISEASES, INBORN; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GERM-LINE MUTATION; HUMANS; MALE; NEOPLASTIC SYNDROMES, HEREDITARY; RISK FACTORS;

EID: 84943235421     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2015.07.021     Document Type: Article

References (109)

1. D. Lieberman, M. Moravec, J. Holub, and et al. Polyp size and advanced histology in patients undergoing colonoscopy screening: implications for CT colonography Gastroenterology 135 2008 1100 1105
2. S.J. Winawer, A.G. Zauber, M.N. Ho, and et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup N Engl J Med 329 1993 1977 1981
3. B. Levin, D.A. Lieberman, B. McFarland, and et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology Gastroenterology 134 2008 1570 1595
4. R.L. Siegel, A. Jemal, and E.M. Ward Increase in incidence of colorectal cancer among young men and women in the United States Cancer Epidemiol Biomarkers Prev 18 2009 1695 1698
5. C.S. Fuchs, E.L. Giovannucci, G.A. Colditz, and et al. A prospective study of family history and the risk of colorectal cancer N Engl J Med 331 1994 1669 1674
6. K.W. Jasperson, T.M. Tuohy, D.W. Neklason, and et al. Hereditary and familial colon cancer Gastroenterology 138 2010 2044 2058
7. H. Bussey, A. Veale, and B. Morson Genetics of gastrointestinal polyposis Gastroenterology 74 1978 1325 1330
8. H.F. Vasen, P. Watson, J.P. Mecklin, and et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC Gastroenterology 116 1999 1453 1456
9. N.M. Lindor, K. Rabe, G.M. Petersen, and et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X JAMA 293 2005 1979 1985
10. S.D. Markowitz, and M.M. Bertagnolli Molecular origins of cancer: molecular basis of colorectal cancer N Engl J Med 361 2009 2449 2460
11. G.M. Petersen, J. Slack, and Y. Nakamura Screening guidelines and premorbid diagnosis of familial adenomatous polyposis using linkage Gastroenterology 100 1991 1658 1664
12. E.R. Fearon, and B. Vogelstein A genetic model for colorectal tumorigenesis Cell 61 1990 759 767
13. Cancer Genome Atlas Network Comprehensive molecular characterization of human colon and rectal cancer Nature 487 7407 2012 330 337
14. A.L. Moisio, H. Jarvinen, and P. Peltomaki Genetic and clinical characterisation of familial adenomatous polyposis: a population based study Gut 50 2002 845 850
15. F.M. Giardiello, A.J. Krush, G.M. Petersen, and et al. Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation Gastroenterology 106 1994 1542 1547
16. M. Miyaki, M. Konishi, R. Kikuchi-Yanoshita, and et al. Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors Cancer Res 54 1994 3011 3020
17. L. Spirio, S. Olschwang, J. Groden, and et al. Alleles of the APC gene: an attenuated form of familial polyposis Cell 75 1993 951 957
18. K.W. Kinzler, M.C. Nilbert, L.K. Su, and et al. Identification of FAP locus genes from chromosome 5q21 Science 253 5020 1991 661 665
19. J. Groden, A. Thliveris, W. Samowitz, and et al. Identification and characterization of the familial adenomatous polyposis coli gene Cell 66 1991 589 600
20. A. Rohlin, Y. Engwall, K. Fritzell, and et al. Inactivation of promoter 1B of APC causes partial gene silencing: evidence for a significant role of the promoter in regulation and causative of familial adenomatous polyposis Oncogene 30 2011 4977 4989
21. S. Aretz, D. Stienen, N. Friedrichs, and et al. Somatic APC mosaicism: a frequent cause of familial adenomatous polyposis (FAP) Hum Mutat 28 2007 985 992
22. N. Al-Tassan, N.H. Chmiel, J. Maynard, and et al. Inherited variants of MYH associated with somatic G: C→T: A mutations in colorectal tumors Nat Genet 30 2002 227 232
23. O.M. Sieber, L. Lipton, M. Crabtree, and et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH N Engl J Med 348 2003 791 799
24. W.S. Jo, P. Bandipalliam, K.M. Shannon, and et al. Correlation of polyp number and family history of colon cancer with germline MYH mutations Clin Gastroenterol Hepatol 3 2005 1022 1028
25. S. Grover, F. Kastrinos, E.W. Steyerberg, and et al. Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas JAMA 308 2012 485 492
26. L. Wang, L.M. Baudhuin, L.A. Boardman, and et al. MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps Gastroenterology 127 2004 9 16
27. S. Vogt, N. Jones, D. Christian, and et al. Expanded extracolonic tumor spectrum in MUTYH-associated polyposis Gastroenterology 137 2009 1976 1985 e1971-e1910
28. F. Balaguer, S. Castellvi-Bel, A. Castells, and et al. Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study Clin Gastroenterol Hepatol 5 2007 379 387
29. E. Theodoratou, H. Campbell, A. Tenesa, and et al. A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants Br J Cancer 103 2010 1875 1884
30. A.K. Win, J.G. Dowty, S.P. Cleary, and et al. Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer Gastroenterology 146 2014 1208 1211 e1201-e1205
31. National Comprehensive Cancer Network. NCCN Clinical practice guidelines in oncology. Genetic/familial high risk assessment: colorectal. Published 2014, v. 2.2014. Available at: nccn.org. Accessed June 2015.
32. F.M. Giardiello, J.D. Brensinger, and G.M. Petersen AGA technical review on hereditary colorectal cancer and genetic testing Gastroenterology 121 2001 198 213
33. H. Hampel, R.L. Bennett, A. Buchanan, and et al. A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment Genet Med 17 2015 70 87
34. S. Syngal, R.E. Brand, J.M. Church, and et al. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes Am J Gastroenterol 110 2015 223 262 quiz 263
35. J. Balmana, F. Balaguer, A. Cervantes, et al. ESMO Guidelines Work Group Familial risk-colorectal cancer: ESMO Clinical Practice Guidelines Ann Oncol 24 Suppl 6 2013 vi73 vi80
36. C. Palles, J.B. Cazier, K.M. Howarth, and et al. Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas Nat Genet 45 2013 136 144
37. S. Briggs, and I. Tomlinson Germline and somatic polymerase epsilon and delta mutations define a new class of hypermutated colorectal and endometrial cancers J Pathol 230 2013 148 153
38. I. Spier, S. Holzapfel, J. Altmuller, and et al. Frequency and phenotypic spectrum of germline mutations in POLE and seven other polymerase genes in 266 patients with colorectal adenomas and carcinomas Int J Cancer 137 2015 320 331
39. M.G. van Lier, A. Wagner, E.M. Mathus-Vliegen, and et al. High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations Am J Gastroenterol 105 2010 1258 1264 author reply 1265
40. F.M. Giardiello, and J.D. Trimbath Peutz-Jeghers syndrome and management recommendations Clin Gastroenterol Hepatol 4 2006 408 415
41. J.R. Howe, F.A. Mitros, and R.W. Summers The risk of gastrointestinal carcinoma in familial juvenile polyposis Ann Surg Oncol 5 1998 751 756
42. F. Schwenter, M.E. Faughnan, A.B. Gradinger, and et al. Juvenile polyposis, hereditary hemorrhagic telangiectasia, and early onset colorectal cancer in patients with SMAD4 mutation J Gastroenterol 47 2012 795 804
43. K. Sweet, J. Willis, X.P. Zhou, and et al. Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis JAMA 294 2005 2465 2473
44. B. Heald, J. Mester, L. Rybicki, and et al. Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers Gastroenterology 139 2010 1927 1933
45. J.M. Carethers, F.B. Furnari, A.F. Zigman, and et al. Absence of PTEN/MMAC1 germ-line mutations in sporadic Bannayan-Riley-Ruvalcaba syndrome Cancer Res 58 1998 2724 2726
46. D.C. Snover, D. Ahnen, R. Burt, and et al. Serrated polyps of the colon and rectum and serrated polyposis F.T. Bosman, F. Carniero, R. Hruban, WHO Classification of Tumours of the Digestive System 4 ed. 2010 IARC Lyon, France Chapter 8
47. R.H. Lash, R.M. Genta, and C.M. Schuler Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients J Clin Pathol 63 2010 681 686
48. C.J. Kahi, D.G. Hewett, D.L. Norton, and et al. Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy Clin Gastroenerol Hepatol 9 2011 42 46
49. B. Leggett, and V. Whitehall Role of the serrated pathway in colorectal cancer pathogenesis Gastroenterology 138 2010 2088 2100
50. D.C. Snover Update on the serrated pathway to colorectal carcinoma Hum Pathol 42 2011 1 10
51. M.F. Kalady, A. Jarrar, B. Leach, and et al. Defining phenotypes and cancer risk in hyperplastic polyposis syndrome Dis Colon Rectum 54 2011 164 170
52. M.K. Gala, Y. Mizukami, L.P. Le, and et al. Germline mutations in oncogene-induced senescence pathways are associated with multiple sessile serrated adenomas Gastroenterology 146 2014 520 529
53. K.S. Boparai, E. Dekker, S. Van Eeden, and et al. Hyperplastic polyps and sessile serrated adenomas as a phenotypic expression of MYH-associated polyposis Gastroenterology 135 2008 2014 2018
54. J.P. Terdiman, and K.R. McQuaid Surveillance guidelines should be updated to recognize the importance of serrated polyps Gastroenterology 139 2010 1444 1447
55. K.S. Boparai, E.M. Mathus-Vliegen, J.J. Koornstra, and et al. Increased colorectal cancer risk during follow-up in patients with hyperplastic polyposis syndrome: a multicentre cohort study Gut 59 2010 1094 1100
56. D.K. Rex, D.J. Ahnen, J.A. Baron, and et al. Serrated lesions of the colorectum: review and recommendations from an expert panel Am J Gastroenterol 107 2012 1315 1329 quiz 1314, 1330
57. J. Ngeow, B. Heald, L.A. Rybicki, and et al. Prevalence of germline PTEN, BMPR1A, SMAD4, STK11, and ENG mutations in patients with moderate-load colorectal polyps Gastroenterology 144 2013 1402 1409 1409 e1401-e1405
58. C.R. Boland, S.N. Thibodeau, S.R. Hamilton, and et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer Cancer Res 58 1998 5248 5257
59. H. Hampel, W.L. Frankel, E. Martin, and et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer) N Engl J Med 352 2005 1851 1860
60. C.R. Boland, and H.T. Lynch The history of Lynch syndrome Fam Cancer 12 2013 145 157
61. F. Quehenberger, H.F. Vasen, and H.C. van Houwelingen Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment J Med Genet 42 2005 491 496
62. M.A. Jenkins, L. Baglietto, J.G. Dowty, and et al. Cancer risks for mismatch repair gene mutation carriers: a population-based early onset case-family study Clin Gastroenterol Hepatol 4 2006 489 498
63. E. Stoffel, B. Mukherjee, V.M. Raymond, and et al. Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome Gastroenterology 137 2009 1621 1627
64. M. Aarnio, R. Sankila, E. Pukkala, and et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes Int J Cancer 81 1999 214 218
65. H.J. Jarvinen, L. Renkonen-Sinisalo, K. Aktan-Collan, and et al. Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members J Clin Oncol 27 2009 4793 4797
66. C. Engel, N. Rahner, K. Schulmann, and et al. Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer Clin Gastroenterol Hepatol 8 2010 174 182
67. D.L. Edelstein, J. Axilbund, M. Baxter, and et al. Rapid development of colorectal neoplasia in patients with Lynch syndrome Clin Gastroenterol Hepatol 9 2011 340 343
68. H.T. Lynch, and A. de la Chapelle Hereditary colorectal cancer N Engl J Med 348 2003 919 932
69. P. Peltomaki Lynch syndrome genes Fam Cancer 4 2005 227 232
70. J.M. Carethers, E.J. Smith, C.A. Behling, and et al. Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer Gastroenterology 126 2004 394 401
71. R. Gryfe, H. Kim, E.T. Hsieh, and et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer N Engl J Med 342 2000 69 77
72. F.M. Giardiello, J.I. Allen, J.E. Axilbund, and et al. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer Gastroenterology 147 2014 502 526
73. F. Kastrinos, E.M. Stoffel, J. Balmana, and et al. Phenotype comparison of MLH1 and MSH2 mutation carriers in a cohort of 1,914 individuals undergoing clinical genetic testing in the United States Cancer Epidemiol Biomarkers Prev 17 2008 2044 2051
74. L. Senter, M. Clendenning, K. Sotamaa, and et al. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations Gastroenterology 135 2008 419 428
75. L. Baglietto, N.M. Lindor, J.G. Dowty, and et al. Risks of Lynch syndrome cancers for MSH6 mutation carriers J Natl Cancer Inst 102 2010 193 201
76. M.L. Goodenberger, B.C. Thomas, D. Riegert-Johnson, and et al. PMS2 monoallelic mutation carriers: the known unknown Genet Med 2015 Apr 9 http://dx.doi.org/10.1038/gim.2015.27 [Epub ahead of print]
77. M.J. Ligtenberg, R.P. Kuiper, T.L. Chan, and et al. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1 Nat Genet 41 2009 112 117
78. M.J. Ligtenberg, R.P. Kuiper, A. Geurts van Kessel, and et al. EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients Fam Cancer 12 2013 169 174
79. H.T. Lynch, D.L. Riegert-Johnson, C. Snyder, and et al. Lynch syndrome-associated extracolonic tumors are rare in two extended families with the same EPCAM deletion Am J Gastroenterol 106 2011 1829 1836
80. J. Mueller, I. Gazzoli, P. Bandipalliam, and et al. Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases Cancer Res 69 2009 7053 7061
81. G.E. Palomaki, M.R. McClain, S. Melillo, and et al. EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome Genet Med 11 2009 42 65
82. A.R. Mensenkamp, I.P. Vogelaar, W.A. van Zelst-Stams, and et al. Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors Gastroenterology 146 2014 643 646 e648
83. C.M. Suter, D.I. Martin, and R.L. Ward Germline epimutation of MLH1 in individuals with multiple cancers Nat Genet 36 2004 497 501
84. M.P. Hitchins, J.J. Wong, G. Suthers, and et al. Inheritance of a cancer-associated MLH1 germ-line epimutation N Engl J Med 356 2007 697 705
85. M.P. Hitchins, R.W. Rapkins, C.T. Kwok, and et al. Dominantly inherited constitutional epigenetic silencing of MLH1 in a cancer-affected family is linked to a single nucleotide variant within the 5'UTR Cancer Cell 20 2011 200 213
86. K.M. Schmeler, H.T. Lynch, L.M. Chen, and et al. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome N Engl J Med 354 2006 261 269
87. H.J. Jarvinen, M. Aarnio, H. Mustonen, and et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer Gastroenterology 118 2000 829 834
88. J.P. Mecklin, M. Aarnio, E. Laara, and et al. Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome Gastroenterology 133 2007 1093 1098
89. H.F. Vasen, M. Abdirahman, R. Brohet, and et al. One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome Gastroenterology 138 2010 2300 2306
90. X. Llor, E. Pons, R.M. Xicola, and et al. Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathway Clin Cancer Res 11 2005 7304 7310
91. T.T. Nieminen, W.M. Abdel-Rahman, A. Ristimaki, and et al. BMPR1A mutations in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency Gastroenterology 141 2011 e23 e26
92. T.T. Nieminen, M.F. O'Donohue, Y. Wu, and et al. Germline mutation of RPS20, encoding a ribosomal protein, causes predisposition to hereditary nonpolyposis colorectal carcinoma without DNA mismatch repair deficiency Gastroenterology 147 2014 595 598 e595
93. E. Schulz, P. Klampfl, S. Holzapfel, and et al. Germline variants in the SEMA4A gene predispose to familial colorectal cancer type X Nat Commun 5 2014 5191
94. C. Wei, B. Peng, Y. Han, and et al. Mutations of HNRNPA0 and WIF1 predispose members of a large family to multiple cancers Fam Cancer 14 2015 297 306
95. M.B. Yurgelun, S. Masciari, V.A. Joshi, and et al. Germline mutations in patients with early-onset colorectal cancer in the Colon Cancer Family Registry JAMA Oncol 1 2 2015
96. M.B. Yurgelun, B. Allen, R.R. Kaldate, and et al. Identification of a variety of mutations in cancer predisposition genes in patients with suspected Lynch syndrome Gastroenterology 2015 May 14 pii: S0016-5085(15)00678-2 http://dx.doi.org/10.1053/j.gastro.2015.05.006 [Epub ahead of print]
97. C.M. Phelan, J. Iqbal, H.T. Lynch, and et al. Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study Br J Cancer 110 2014 530 534
98. L. Moreira, F. Balaguer, N. Lindor, and et al. Identification of Lynch syndrome among patients with colorectal cancer JAMA 308 2012 1555 1565
99. Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives Genet Med 11 2009 35 41
100. S. Chen, W. Wang, S. Lee, and et al. Prediction of germline mutations and cancer risk in the Lynch syndrome JAMA 296 2006 1479 1487
101. F. Kastrinos, E.W. Steyerberg, R. Mercado, and et al. The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history Gastroenterology 140 2011 73 81
102. T.A. Dinh, B.I. Rosner, J.C. Atwood, and et al. Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population Cancer Prev Res 4 2011 9 22
103. M.E. Robson, C.D. Storm, J. Weitzel, et al. American Society of Clinical Oncology American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility J Clin Oncol 28 2010 893 901
104. K.H. Lu, M.E. Wood, M. Daniels, and et al. American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers J Clin Oncol 32 2014 833 840
105. A.W. Kurian, E.E. Hare, M.A. Mills, and et al. Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment J Clin Oncol 32 2014 2001 2009
106. T. Walsh, S. Casadei, M.K. Lee, and et al. Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing Proc Natl Acad Sci U S A 108 2011 18032 18037
107. S.M. Domchek, A. Bradbury, J.E. Garber, and et al. Multiplex genetic testing for cancer susceptibility: out on the high wire without a net? J Clin Oncol 31 2013 1267 1270
108. A. Umar, C.R. Boland, J.P. Terdiman, and et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability J Natl Cancer Inst 96 2004 261 268
109. S. Syngal, R.E. Brand, J.M. Chruch, and et al. ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes Am J Gastroenterol 110 2015 223 262